Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04681820 |
|---|---|
| Brief Title: | Evaluating Efficacy and Safety of Flumatinib Versus Nilotinib for Chronic Phase Chronic Myeloid Leukemia(CML-CP) Without Optimal Response (Warning,Failure) to Imatinib or Dasatinib |
| First Submitted : | December 18, 2020 |
| First Submitted that Met QC Criteria : | December 18, 2020 |
| First Posted : | December 23, 2020 |
| Last Update Submitted that Met QC Criteria : | May 31, 2021 |
| Last Update Posted : | June 3, 2021 |